ARCHITECT I CARBAMAZEPINE 01P36-25

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2016-08-15 for ARCHITECT I CARBAMAZEPINE 01P36-25 manufactured by Abbott Germany.

Event Text Entries

[52070224] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[52070285] The customer observed false elevated carbamazepine patient results generated using the architect carbamazepine reagents. The following data was provided (ug/ml). Initial >20, diluted and repeated 28. Repeat 5. 6, 28, 14. 9. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[55702982] Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, review of field data, and a review of labeling. No adverse trend was identified for the customer issue. Device history review did not identify any issues that may have caused the customer issue. Labeling was reviewed and found to be adequate. The product was not available for return. Review of field data showed the median value of the complaint lot was within the range of median values for other lots in the field between (b)(6) 2015 and (b)(6) 2016, and no issue for the complaint lot was identified. Based on all available information and abbott diagnostics' complaint investigation, the assay performed as intended and no product deficiency was identified.
Patient Sequence No: 1, Text Type: N, H10


[74810291] The device evaluation was reassessed and concluded that a malfunction occurred, the device did not perform as intended. However, no systematic issue or product deficiency was identified. Conclusion code was corrected.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002809144-2016-00055
MDR Report Key5875050
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2016-08-15
Date of Report2017-04-26
Date Mfgr Received2017-04-10
Device Manufacturer Date2015-09-17
Date Added to Maude2016-08-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT GERMANY
Manufacturer StreetMAX-PLANCK-RING 2
Manufacturer CityWIESBADEN 65205
Manufacturer CountryGM
Manufacturer Postal Code65205
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT I CARBAMAZEPINE
Generic NameENZYME IMMUNOASSAY, CARBAMAZEPINE
Product CodeKLT
Date Received2016-08-15
Catalog Number01P36-25
Lot Number57085LI00
Device Expiration Date2016-09-07
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT GERMANY
Manufacturer AddressMAX-PLANCK-RING 2 WIESBADEN 65205 GM 65205


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.